695 results on '"Petersdorf, Effie W."'
Search Results
2. The Association of HLA-E Ligand and NKG2 Receptor Variation With Relapse and Mortality After Haploidentical Related Donor Transplantation
3. Decreasing chronic graft-versus-host disease rates in all populations
4. Interplay between donor age and HLA-DP matching in 10/10 HLA-matched unrelated donor HCT
5. HLA structure and function in hematopoietic-cell transplantation
6. Combined effect of unrelated donor age and HLA peptide-binding motif match status on HCT outcomes
7. Assessment of HLA-DPB1 genetic variation using an HLA-DP tool and its implications in clinical transplantation
8. Role of NKG2D ligands and receptor in haploidentical related donor hematopoietic cell transplantation
9. A Tool for the Assessment of HLA-DQ Heterodimer Variation in Hematopoietic Cell Transplantation
10. Haploidentical Versus Mismatched Unrelated Donor Hematopoietic Cell Transplantation: HLA Factors and Donor Age Considerations
11. HLA-DQ heterodimers in hematopoietic cell transplantation
12. HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide
13. Assessment of HLA-B genetic variation with an HLA-B leader tool and implications in clinical transplantation
14. KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation
15. HLA-A alleles influencing NK cell function impact AML relapse following allogeneic hematopoietic cell transplantation
16. Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen–mismatched donors
17. HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation
18. Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study
19. Assessment of HLA-DQ Genetic Variation with an HLA-DQ Heterodimers Tool and Implications in Clinical Transplantation
20. The MHC in the era of next-generation sequencing: Implications for bridging structure with function
21. HLA Haplotypes and Relapse After Hematopoietic Cell Transplantation
22. HLA Typing in Support of Hematopoietic Cell Transplantation from Unrelated Donors
23. Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility
24. Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most
25. Race and Survival in Unrelated Hematopoietic Cell Transplantation
26. Hematopoietic Cell Transplantation for Myelofibrosis: the Dynamic International Prognostic Scoring System Plus Risk Predicts Post-Transplant Outcomes
27. Predicting an HLA-DPB1 expression marker based on standard DPB1 genotyping: Linkage analysis of over 32,000 samples
28. Which factors influence the development of GVHD in HLA-matched or mismatched transplants?
29. HLA Haplotypes and Relapse After Hematopoietic Cell Transplantation.
30. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Research Methodology and Study Design Working Group Report
31. Definition of HLA-DQ as a Transplantation Antigen
32. Mismatched unrelated donor transplantation
33. Impact of Allele-Level HLA Mismatch on Outcomes in Recipients of Double Umbilical Cord Blood Transplantation
34. In Memoriam: John A. Hansen
35. Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation
36. Supplemental Table 1 from Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia
37. Supplemental Figure 1 from Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia
38. Supplemental Table 2 from Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia
39. Supplemental Table 3 from Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia
40. Supplemental Table 4 from Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia
41. A population-based case–control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancers
42. Center for International Blood and Marrow Transplant Research Chronic Graft-versus-Host Disease Risk Score Predicts Mortality in an Independent Validation Cohort
43. HLA Typing in Support of Hematopoietic Cell Transplantation from Unrelated Donors
44. Fresh Versus Cryopreserved Allograft Outcomes in Peripheral Blood Stem Cell Transplantations
45. HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation
46. Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation
47. Contributors
48. Unrelated Donor Hematopoietic Cell Transplantation
49. Stem Cell Transplantation for Hematologic Malignancies
50. HLA Typing in Support of Hematopoietic Cell Transplantation from Unrelated Donors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.